• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND RESOLUTE INTEGRITY RX; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND RESOLUTE INTEGRITY RX; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Lot Number UNKNOWN
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Stroke/CVA (1770); Myocardial Infarction (1969); Thrombus (2101); Blood Loss (2597); Patient Problem/Medical Problem (2688)
Event Date 09/19/2018
Event Type  Injury  
Manufacturer Narrative
Concomitant medical products: dapt - clopidogrel and aspirin.Ticgrelor and prasugrel.(b)(4).Journal article: randomized all-comers evaluation of a permanent polymer zotarolimus-eluting stent versus a polymer-free amphilimus-eluting stent.Title: journal: american heart association, inc year: 2019 ref: doi: 10.1161/circulationaha.118.037707.Age or date of birth: average age.Sex: majority gender date of event: date of publication.If information is provided in the future, a supplemental report will be issued.
 
Event Description
This study investigates the clinical safety and efficacy of polymer-free amphilimus-eluting stents( pf-aes) as compared with latest generation permanent-polymer zotarolimus-eluting stents (pp-zes).Between nov 3, 2014 and july 10, 2017, 1502 eligible all-comers patients with 2133 lesions, aged 29 to 93 years, consented to study enrollment.Pp-zes used were resolute integrity drug eluting stents.Pf-aes used were non medtronic stents.Lesions treated with resolute integrity included left main, left anterior descending artery, left circumflex artery, right coronary artery, arterial bypass graft, venous bypass graft.Clinical outcomes reported included death , cardiac death, myocardial infarction, stent thrombosis, revascularization, stroke and major bleeding.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RESOLUTE INTEGRITY RX
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key8538694
MDR Text Key142735830
Report Number9612164-2019-01435
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeNL
PMA/PMN Number
P110013
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 04/23/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/23/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/24/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age65 YR
-
-